Diacomit

Diacomit Warnings and Precautions

• Suicidal thoughts and behavior: As with other anticonvulsants, patients should be monitored for new or worsening depression, suicidal thoughts, agitation, aggression, or panic attacks.
• Somnolence: Very common, especially when combined with clobazam. If somnolence occurs, an initial 25% reduction in clobazam dose may be considered.
• Drug interaction with clobazam: Diacomit increases clobazam and its active metabolite levels — the combination requires careful dose management by the treating doctor.

How to Access Diacomit in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Diacomit to India?

Diacomit (stiripentol) capsules may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified neurologist
• The patient's diagnostic reports confirming Dravet syndrome
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Diacomit available in India?

Diacomit (stiripentol capsules) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Diacomit is not commercially marketed in India.

However, patients in India can legally access Diacomit through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Diacomit received US FDA approval in 2018 for seizures associated with Dravet syndrome, ensuring full transparency throughout the process.

Diacomit can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

For patients with Dravet syndrome, NPP also facilitates access to Epidiolex, another anti-seizure therapy sometimes used alongside Diacomit, based on the treating neurologist's assessment.

Sourcing & Delivery of Diacomit

Diacomit is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 15°C to 30°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Diacomit Across Major Cities in India

Named Patient Program supports access to Diacomit for patients with Dravet syndrome across major cities in India, coordinating documentation, sourcing, and delivery with treating neurologists.

Mumbai

Patients in Mumbai can access Diacomit through NPP with support from treating pediatric neurologists.

Delhi

In Delhi, NPP coordinates with hospitals and specialty epilepsy clinics to facilitate timely access to Diacomit.

Bangalore

Bangalore's pediatric neurology centers work with NPP to support patients requiring Diacomit.

Chennai

Patients in Chennai can access Diacomit through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's neurology and epilepsy centers support diagnosis and access coordination for Diacomit through NPP.

Kolkata

NPP facilitates access to Diacomit for patients in Kolkata under the guidance of treating neurologists.

Pune

Patients in Pune can access Diacomit through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Diacomit for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Diacomit through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Diacomit for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Diacomit through NPP with support from treating neurologists.

Lucknow

NPP facilitates access to Diacomit for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Diacomit through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Diacomit for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.